enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)

CUSIP: 29415J106

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
20,505,656
Total 13F shares
2,080,875
Share change
+1,994,190
Total reported value
$13,711,600
Put/Call ratio
3.4%
Price per share
$6.59
Number of holders
23
Value change
+$13,093,583
Number of buys
22
Number of sells
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 29415J106?
CUSIP 29415J106 identifies NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MARSHALL WACE, LLP
13F
Company
0.06%
12,207
$127,000 30 Sep 2021
13F

Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q4 2021

As of 31 Dec 2021, enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,080,875 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ACT CAPITAL MANAGEMENT, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, Velan Capital Investment Management LP, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and Kepos Capital LP. This page lists 23 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
1
Q4 2021 holders
23
Holder diff
22
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.